Tobacco and metabolic syndrome
- PMID: 22276256
- PMCID: PMC3263202
- DOI: 10.4103/2230-8210.91197
Tobacco and metabolic syndrome
Abstract
Tobacco is a leading contributor to morbidity and mortality globally. Metabolic syndrome is a constellation of abdominal obesity, atherogenic dyslipidemia, raised blood pressure, insulin resistance (with and without glucose intolerance), pro-inflammatory state, and pro-thrombotic state. Tobacco use is associated with various core components of metabolic syndrome. It has been found to play a causal role in various pathways leading on to development this condition, the current article discusses various facets of this association.
Keywords: Metabolic syndrome; second-hand smoke; tobacco.
Conflict of interest statement
References
-
- Smoking and health: Joint report of the Study Group on Smoking and Health. Science. 1957;125:1129–33. - PubMed
-
- Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Washington, DC: Oxford University Press and The World Bank; 2006. Global burden of disease and risk factors. - PubMed
-
- Öberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: A retrospective analysis of data from 192 countries. Lancet. 2011;377:139–46. - PubMed
-
- Geneva: World Health Organisation; 2009. WHO report on the global tobacco epidemic, 2009: Implementing smoke-free environments. France.
